Home
About
Investors
- Investment Philosophy
Corporates
Listed
Unlisted
News
Contact
Sign Up

Sateva Acquisition Progress

Jan 21, 2021

ASX News K2Fly

Send
Share
Share

Related Posts

57% Reduction in Total Cholesterol from Nyrada’s NYX-PCSK9i In Vivo Study

Jan 25, 2021 |

ASX News, Nyrada Inc (ASX:NYR)

Incannex engages Procaps to manufacture IHL-42X soft-gel capsules in preparation for pivotal clinical trials

Oct 20, 2021 |

ASX News, Incannex Healthcare (ASX:IHL)

Exopharm Science Webinar – Overcoming the Nucleic Acid Delivery Challenge

Aug 26, 2021 |

ASX News, Exopharm (ASX:EX1)

EX1 : Positive PLEXOVAL II Phase 1 Clinical Trial Results with Off-the-Shelf Plexaris™

Apr 6, 2021 |

ASX News, Exopharm (ASX:EX1)

GET INVESTMENT OPPORTUNITIES OR
RAISE CAPITAL

Contact Us

Home
About
Investors
- Investment Philosophy
Corporates

Listed
Unlisted

Latest News
Contact

CANARY CAPITAL PTY LTD

ABN 18 618 657 640
CAR number 1254859
Of BR Securities Australia Pty Ltd
Holder of AFSL 456663
Level 5/20 Bond St,
Sydney NSW 2000,
AUSTRALIA

Phone: +61 2 8052 9519

Privacy Policy
Terms of Service
Disclaimer
Financial Services Guide

© 2022 Canary Capital | Web Development by Argon